Best Healthcare Stock to Buy: Oscar Health (OSCR) Stock Analysis Q1 2025

Oscar Health Overview & Mission

• 💡 Oscar Health (OSCR) aims to revolutionize health insurance using technology, offering plans in individual, small group, and Medicare Advantage markets across 18 states with over 2 million members.
• ✅ Services include telemedicine, transparent claims, pricing, and incentives for health goals, differentiating it in the competitive healthcare sector.

Strong Q1 2025 Financial Performance

• 📈 Reported Q1 2025 revenue of $3.04 billion, a 42.2% increase year-over-year, alongside a significant rise in EPS to 92 cents.
• 💰 Trailing 12-month (TTM) revenue climbed to $10.08 billion (54.26% YOY), with free cash flow per share TTM surging to $443, marking an extraordinary improvement from the prior year.
• 📊 Profitability margins show a positive trend, including a gross profit margin of 20.28% and a net profit margin of 1.22%, indicating efficient resource management.

Growth Potential & Strategic Initiatives

• 🚀 Achieved robust membership growth of 41% year-over-year in Q1 2025, reaching 2 million effectuated members, driven by retention and new acquisitions.
• 🧠 Leverages AI and data science for personalized healthcare services and has seen accelerated demand for its 24/7 virtual care platform.
• 🤝 Strategic partnerships with giants like Sigma and Cleveland Clinic expand its network, while Aetna's exit from the ACA marketplace presents a significant opportunity to attract new members.

Stock Valuation & Analyst Outlook

• 📉 Despite a 25.1% decline over the past year and underperformance since its 2021 IPO, Oscar Health's current valuation metrics suggest it may be undervalued.
• 🎯 Key valuation ratios like price-to-sales TTM of 0.41 and a price-to-free cash flow TTM of 3.52 indicate an attractive opportunity for growth investors.
• 🔮 Analysts project continued growth, with revenue reaching $11.24 billion and EPS growing to 77 cents in 2025, though some maintain a conservative "sell" rating due to potential subsidy expiration.

Key Risks for Investors

• ⚠️ A major risk is the reliance on Affordable Care Act (ACA) subsidies, which are set to expire at the end of 2025, potentially impacting financial performance.
• 🥊 Oscar faces intense competition from large national insurers such as UnitedHealth Group, Anthem, and CVS Health, which possess extensive resources and networks.
• 📝 Dependence on quota share reinsurance agreements for capital and risk mitigation poses a risk if regulatory approvals or favorable renewals are not secured.